Journal List > J Korean Ophthalmol Soc > v.55(9) > 1009771

Kang, Choe, Choi, and Kim: Comparison of Clinical Results between Transepithelial Photorefractive Keratectomy and Brush Photorefractive Keratectomy

Abstract

Purpose

To compare the results of transepithelial photorefractive keratectomy (trans PRK) and brush-assisted photorefractive keratectomy (brush PRK) for the treatment of myopia.

Methods

A total of 146 eyes from 78 patients who received brush PRK or trans PRK with the Schwind Amaris laser platform were included in the present study. Uncorrected distance visual acuity (UDVA) and manifest refraction spherical equivalent (MRSE) at postoperative 1 week, 1, 3, 6, and 12 months were compared between the 2 groups as well as epithelial healing time.

Results

The mean time to complete epithelial healing was 3.27 ± 0.75 days in the trans PRK group and 3.67 ± 0.93 days in the brush PRK group (p < 0.05). At 1 week after surgery, UDVA recovered more rapidly after trans PRK than brush PRK (brush PRK: 0.13 ± 0.12 log MAR units, trans PRK: 0.09 ± 0.08 log MAR units, p < 0.05), however, UDVA was not significantly different at 1, 3, 6, and, 12 months postoperatively between the 2 groups.

Conclusions

Re-epithelialization and visual recovery were faster in the trans PRK group while visual outcome and postoperative complications were equivalent to the brush PRK group.

References

1. Abad JC, Talamo JH, Vidaurri-Leal J, et al. Dilute ethanol versus mechanical debridement before photorefractive keratectomy. J Cataract Refract Surg. 1996; 22:1427–33.
crossref
2. Amoils SP. Photorefractive keratectomy using a scanning-slit laser, rotary epithelial brush, and chilled balanced salt solution. J Cataract Refract Surg. 2000; 26:1596–604.
3. Lee YG, Chen WY, Petroll WM, et al. Corneal haze after photorefractive keratectomy using different epithelial removal techniques: mechanical debridement versus laser scrape. Ophthalmology. 2001; 108:112–20.
4. Pallikaris IG, Naoumidi II, Kalyvianaki MI, Katsanevaki VJ. Epi-LASIK: comparative histological evaluation of mechanical and alcohol-assisted epithelial separation. J Cataract Refract Surg. 2003; 29:1496–501.
crossref
5. Lee HK, Lee KS, Kim JK, et al. Epithelial healing and clinical outcomes in excimer laser photorefractive surgery following three epithelial removal techniques: mechanical, alcohol, and excimer laser. Am J Ophthalmol. 2005; 139:56–63.
crossref
6. Steinert RF. Wound healing anomalies after excimer laser photorefractive keratectomy: correlation of clinical outcomes, corneal topography, and confocal microscopy. Trans Am Ophthalmol Soc. 1997; 95:629–714.
7. Pallikaris IG, Karoutis AD, Lydataki SE, Siganos DS. Rotating brush for fast removal of corneal epithelium. J Refract Corneal Surg. 1994; 10:439–42.
crossref
8. Griffith M, Jackson WB, Lafontaine MD, et al. Evaluation of current techniques of corneal epithelial removal in hyperopic photorefractive keratectomy. J Cataract Refract Surg. 1998; 24:1070–8.
crossref
9. Fadlallah A, Fahed D, Khalil K, et al. Transepithelial photorefractive keratectomy: clinical results. J Cataract Refract Surg. 2011; 37:1852–7.
crossref
10. Aslanides IM, Padroni S, Arba Mosquera S, et al. Comparison of single-step reverse transepithelial all-surface laser ablation (ASLA) to alcohol-assisted photorefractive keratectomy. Clin Ophthalmol. 2012; 6:973–80.
crossref
11. Trokel SL, Srinivasan R, Braren B. Excimer laser surgery of the cornea. Am J Ophthalmol. 1983; 96:710–5.
crossref
12. Hersh PS, Brint SF, Maloney RK, et al. Photorefractive keratectomy versus laser in situ keratomileusis for moderate to high myopia. A randomized prospective study. Ophthalmology. 1998; 105:1512–22.
13. Luger MH, Ewering T, Arba-Mosquera S. Consecutive myopia correction with transepithelial versus alcohol-assisted photorefractive keratectomy in contralateral eyes: one-year results. J Cataract Refract Surg. 2012; 38:1414–23.
crossref
14. Lee SB, Chung MS. Advanced Surface Ablation-Photorefractive Keratectomy (ASA-PRK): Safety and clinical outcome for the correction of mild to moderate myopia with a thin cornea. J Korean Ophthalmol Soc. 2006; 47:1274–86.
15. Sia RK, Ryan DS, Stutzman RD, et al. Alcohol versus brush PRK: visual outcomes and adverse effects. Lasers Surg Med. 2012; 44:475–81.
crossref
16. Kim SY, Sah WJ, Lim YW, Hahn TW. Twenty percent alcohol toxicity on rabbit corneal epithelial cells: electron microscopic study. Cornea. 2002; 21:388–92.
17. Oh JY, Yu JM, Ko JH. Analysis of ethanol effects on corneal epithelium. Invest Ophthalmol Vis Sci. 2013; 54:3852–6.
crossref
18. Kanitkar KD, Camp J, Humble H, et al. Pain after epithelial removal by ethanol-assisted mechanical versus transepithelial excimer laser debridement. J Refract Surg. 2000; 16:519–22.
crossref
19. Choi JY, Kim HC, Seo KY, et al. Refraction and visual outcome between the enhancement methods on regressed or undercorrected myopia after LASIK. J Korean Ophthalmol Soc. 2006; 47:349–54.
20. Sadeghi HM, Seitz B, Hayashi S, et al. In vitro effects of mitomycin-C on human keratocytes. J Refract Surg. 1998; 14:534–40.
crossref
21. Netto MV, Mohan RR, Sinha S, et al. Effect of prophylactic and therapeutic mitomycin C on corneal apoptosis, cellular proliferation, haze, and long-term keratocyte density in rabbits. J Refract Surg. 2006; 22:562–74.
crossref
22. Teus MA, de Benito-Llopis L, Alió JL. Mitomycin C in corneal refractive surgery. Surv Ophthalmol. 2009; 54:487–502.
crossref
23. Gambato C, Ghirlando A, Moretto E, et al. Mitomycin C modulation of corneal wound healing after photorefractive keratectomy in highly myopic eyes. Ophthalmology. 2005; 112:208–18.
crossref
24. Rajan MS, O'Brart DP, Patmore A, Marshall J. Cellular effects of mitomycin-C on human corneas after photorefractive keratectomy. J Cataract Refract Surg. 2006; 32:1741–7.
crossref
25. Lee DH, Chung HS, Jeon YC, et al. Photorefractive keratectomy with intraoperative mitomycin-C application. J Cataract Refract Surg. 2005; 31:2293–8.
crossref
26. Netto MV, Mohan RR, Ambrósio R Jr, et al. Wound healing in the cornea: a review of refractive surgery complications and new prospects for therapy. Cornea. 2005; 24:509–22.
27. Kim WJ, Shah S, Wilson SE. Differences in keratocyte apoptosis following transepithelial and laser-scrape photorefractive keratectomy in rabbits. J Refract Surg. 1998; 14:526–33.
crossref
28. M⊘ller-Pedersen T, Cavanagh HD, Petroll WM, Jester JV. Corneal haze development after PRK is regulated by volume of stromal tissue removal. Cornea. 1998; 17:627–39.
crossref

Table 1.
Preoperative patient characteristics
Brush PRK Trans PRK p-value*
Patients (eyes) 38 (73) 40 (73)
Sex (M/F) 12/26 11/29 0.724
Age (years) 26.3 ± 6.8 28.3 ± 7.1 0.080
CDVA (log MAR) 0.0089 ± 0.0210 0.0048 ± 0.0170 0.196
Sphere (diopter) −5.34 ± 1.49 −5.05 ± 1.25 0.208
Cylinder (diopter) −1.02 ± 0.58 −0.84 ± 0.63 0.061
SE (diopter) −5.85 ± 1.55 −5.46 ± 1.31 0.109
Central corneal thickness (μm) 539 ± 30 536 ± 28 0.480
Mitomycin C use 36 (49%) 33 (45%) 0.622

Values are presented as mean ± SD unless otherwise indicated.

PRK = photorefractive keratectomy; CDVA = corrected distance visual acuity; SE = spherical equivalent.

* T-test, p < 0.05 is statistically significant.

Table 2.
Comparison of epithelial healing time and mean spherical equivalent between Brush PRK and Trans PRK
Brush PRK Trans PRK p-value
Epithelial healing time (days) 3.67 ± 0.93 3.27 ± 0.75 0.005*
SE (diopter)
 1 week 0.1528 ± 0.5403 0.1069 ± 0.5408 0.615
 1 month −0.0522 ± 0.6851 0.0538 ± 0.6335 0.345
 3 months −0.1033 ± 0.6124 −0.0299 ± 0.5080 0.449
 6 months −0.2687 ± 0.7529 −0.1557 ± 0.5355 0.334
 1 year −0.3082 ± 0.5493 −0.1370 ± 0.6223 0.080

Values are presented as mean ± SD.

PRK = photorefractive keratectomy; SE = spherical equivalent.

* T-test, p < 0.05 is statistically significant.

Table 3.
Comparison of mean UDVA (log MAR) between Brush PRK and Trans PRK
Brush PRK Trans PRK p-value
1 week 0.1312 ± 0.1200 0.0899 ± 0.0775 0.017*
1 month 0.0761 ± 0.1689 0.0451 ± 0.0538 0.142
3 months 0.0203 ± 0.0396 0.0231 ± 0.0438 0.692
6 months 0.0261 ± 0.0624 0.0115 ± 0.0334 0.105
12 months 0.0063 ± 0.0188 0.0034 ± 0.0127 0.276

Values are presented as mean ± SD.

UDVA = uncorrected distance visual acuity; PRK = photorefractive keratectomy.

* T-test, p < 0.05 is statistically significant.

Table 4.
Comparison of epithelial healing time, UDVA, SE adjusted by Mitomycin C use
Brush PRK Trans PRK p-value
Mitomycin C use 36 (49%) 33 (45%) 0.622
Epithelial healing time (days) 3.50 ± 0.08 3.14 ± 0.08 0.002*
UDVA (log MAR)
 1 week 0.123 ± 0.014 0.098 ± 0.013 0.253
 1 month 0.050 ± 0.008 0.046 ± 0.008 0.037*
 3 months 0.019 ± 0.005 0.023 ± 0.005 0.230
 6 months 0.018 ± 0.005 0.012 ± 0.005 0.248
 12 months 0.006 ± 0.002 0.003 ± 0.002 0.394
SE (diopter)
 1 week 0.172 ± 0.075 0.127 ± 0.074 0.085
 1 month −0.051 ± 0.092 0.016 ± 0.091 0.382
 3 months −0.119 ± 0.079 −0.064 ± 0.077 0.554
 6 months −0.216 ± 0.088 −0.178 ± 0.087 0.487
 12 months −0.228 ± 0.074 −0.188 ± 0.073 0.912

Values are presented as mean ± SD unless otherwise indicated.

UDVA = uncorrected distance visual acuity; SE = spherical equivalent; PRK = photorefractive keratectomy.

* ANCOVA test, p <0.05 is statistically significant.

TOOLS
Similar articles